ANI PHARMACEUTICALS INC 4
4 · ANI PHARMACEUTICALS INC · Filed Mar 16, 2015
Insider Transaction Report
Form 4
RAYNOR DANIEL
Director
Transactions
- Sale
Common Stock
2015-03-12$63.00/sh−200,000$12,600,000→ 324,182 total(indirect: See Footnote)
Footnotes (1)
- [F1]These shares are held by Argentum Capital Partners II, L.P. (ACP II). Argentum Investments, LLC is the managing member of Argentum Partners II, LLC, which is the general partner of ACP II. Daniel Raynor is a co-managing member of Argentum Investments, LLC. Mr. Raynor disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.